Andrew Ginsberg
Corporate Officer/Principal chez InterVarsity Christian Fellowship USA
Profil
Andrew Ginsberg is currently the Chief Development Officer & EVP-Advancement at InterVarsity Christian Fellowship USA. He previously worked as the Vice President-Marketing & Managing Director at Laboratory Corp.
of America Holdings.
Mr. Ginsberg completed his undergraduate degree at Duke University.
Postes actifs de Andrew Ginsberg
| Sociétés | Poste | Début |
|---|---|---|
InterVarsity Christian Fellowship USA
 InterVarsity Christian Fellowship USA Miscellaneous Commercial ServicesCommercial Services InterVarsity Christian Fellowship USA operates as a campus ministry. It offers group Bible studies, large gatherings on campus, leadership training, thoughtful discipleship and life-changing conferences and events. The company was founded in 1941 and is headquartered in Madison, WI. | Corporate Officer/Principal | 01/07/2010 |
Anciens postes connus de Andrew Ginsberg
| Sociétés | Poste | Fin |
|---|---|---|
| LABCORP HOLDINGS INC. | Sales & Marketing | - |
Formation de Andrew Ginsberg
| Duke University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
InterVarsity Christian Fellowship USA
InterVarsity Christian Fellowship USA Miscellaneous Commercial ServicesCommercial Services InterVarsity Christian Fellowship USA operates as a campus ministry. It offers group Bible studies, large gatherings on campus, leadership training, thoughtful discipleship and life-changing conferences and events. The company was founded in 1941 and is headquartered in Madison, WI. | Commercial Services |
Laboratory Corp. of America Holdings
 Laboratory Corp. of America Holdings Medical/Nursing ServicesHealth Services Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC. | Health Services |
